Lv5
1580 积分 2022-06-20 加入
Adjuvant Treatments for Surgically Resected Non–Small Cell Lung Cancer Harboring EGFR Mutations
1天前
待确认
Osimertinib: A Review in Completely Resected, Early-Stage, EGFR Mutation-Positive NSCLC
1天前
待确认
An international survey on the knowledge, aTtitudes and clinical pAtternS of use of medical cannabis for caNcer care: the TASMAN study
2个月前
已完结
Safety and Efficacy of Adjuvant FOLFOX/FOLFIRI with versus without Hepatic Arterial Infusion of Floxuridine in Patients Following Colorectal Cancer Liver Metastasectomy (HARVEST trial): A Randomized Controlled Trial
2个月前
已完结
[China clinical practice guideline for stage Ⅳ primary lung cancer (2024 edition)]
3个月前
已完结
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
3个月前
已完结
CDKN2A/B homozygous deletion sensitizes IDH-mutant glioma to CDK4/6 inhibition
4个月前
已完结
Genetic interactions reveal distinct biological and therapeutic implications in breast cancer
5个月前
已完结
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies
5个月前
已完结
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA
5个月前
已完结
皖公网安备34019202002308
